戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 evaluated the influence of polymerization of diaspirin alpha-alpha cross-linked Hb (alphaalpha-DBBF-H
2 aortic endothelial cells were incubated with diaspirin cross-linked hemoglobin (DBBF-Hb), developed a
3                                              Diaspirin cross-linked hemoglobin (DCLHb) is an intramol
4 ted with 0.9% saline (group 1, 90 mL/ kg) or diaspirin cross-linked hemoglobin (group 2, 15 mL/kg) fr
5 nd hematologic analyses were measured before diaspirin cross-linked hemoglobin administration and at
6 the main end point to assess the efficacy of diaspirin cross-linked hemoglobin as a vasopressor.
7                                              Diaspirin cross-linked hemoglobin demonstrated a marked
8  changes began within 5 mins of starting the diaspirin cross-linked hemoglobin infusion.
9     This preliminary study demonstrated that diaspirin cross-linked hemoglobin is a potent vasopresso
10 fter pulmonary contusion, resuscitation with diaspirin cross-linked hemoglobin led to pulmonary hyper
11           This vasopressor characteristic of diaspirin cross-linked hemoglobin may have future clinic
12                                              Diaspirin cross-linked hemoglobin solution (25, 50, or 1
13                                              Diaspirin cross-linked hemoglobin solution doses of 25,
14 re no serious adverse events associated with diaspirin cross-linked hemoglobin solution infusion.
15 entrations was observed in 12 subjects after diaspirin cross-linked hemoglobin solution infusion.
16 r control infusion and in six subjects after diaspirin cross-linked hemoglobin solution infusion; no
17                             The half-life of diaspirin cross-linked hemoglobin solution was 2.5 hrs f
18 nd toe temperature were measured to evaluate diaspirin cross-linked hemoglobin solution's pharmacodyn
19                                              Diaspirin cross-linked hemoglobin solution's pressor eff
20 ted increase in blood pressure occurred with diaspirin cross-linked hemoglobin solution.
21 significantly after infusion of 100 mg/kg of diaspirin cross-linked hemoglobin solution; the isoenzym
22 uted tomography scan volume were higher with diaspirin cross-linked hemoglobin than with saline.
23      Administration of 100 mL boluses of 10% diaspirin cross-linked hemoglobin, up to a maximum of 50
24 nd of the experiment in animals infused with diaspirin cross-linked hemoglobin.
25 gic analyses were altered significantly post diaspirin cross-linked hemoglobin.
26                                  Infusion of diaspirin crosslinked hemoglobin (400 mg/kg iv) produced
27                                              Diaspirin crosslinked hemoglobin (DCHb) is a new blood s
28  endothelin in the cardiovascular actions of diaspirin crosslinked hemoglobin (modified) and (unmodif
29 odynamic and regional circulatory effects of diaspirin crosslinked hemoglobin and stroma reduced hemo
30 d mesentery and pancreas were not altered by diaspirin crosslinked hemoglobin in control rats.
31                                              Diaspirin crosslinked hemoglobin is a resuscitative solu
32 significantly increased after treatment with diaspirin crosslinked hemoglobin or stroma reduced hemog
33                                              Diaspirin crosslinked hemoglobin produced an increase in
34                                              Diaspirin crosslinked hemoglobin produces an immediate i
35  and total peripheral vascular resistance by diaspirin crosslinked hemoglobin were significantly bloc
36 blood flow to the heart, spleen, and skin by diaspirin crosslinked hemoglobin were significantly bloc
37 fied, highly purified, and heat pasteurized (diaspirin crosslinked) and unmodified (stroma reduced) h

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。